Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > No one can predict when or if approvals will happen.

<< Previous

Bullboard Posts

Next >>

Comment by Kingofstockston Sep 20, 2021 1:15pm

93 Views

Post# 33887021

RE:RE:RE:RE:No one can predict when or if approvals will happen.

Your statement is 1000% proof you're not even invested in $TBP as that's is not even close to what tbp is doing and this exact topic was discussed... I'll give you a hint clown synthetic and you can perfectly function wow wow wow now go read educate yourself watch some past interviews and if your getting paid to bash DAMN YOU GUYS SUCK

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages